Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Teva, with a $4.25B opioid settlement in hand, eyes return to growth by 2027 | Fierce Pharma
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva reaches $4.25 billion settlement over alleged role in opioid crisis - CBS News
Teva Pharmaceuticals Agrees To $85 Million Settlement With Oklahoma In Opioid Case | KPBS Public Media
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva, one of the biggest generic makers, joins the the brand-name club
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Teva Faces New Class Action—But Could It Afford Another Se...
BCBS Vermont suing Teva Pharmaceuticals over MS drug marketing | Healthcare Finance News
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva profit plummets, stock slides | Ctech
Closure of another criminal case will help Teva's new CEO to focus on return to growt | Ctech
